Suven Life Sciences share news, announcements and annual reports
NSE: SUVENBSE: 530239Healthcare ServicesSmall Cap
Suven Life Sciences Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1995 on BSE, Oct 2003 on NSE
Last close ₹258.85down ₹5.35 (2.03%)BSE ₹258.10
Share price at the NSE close on 30 Oct 2026. Previous close ₹264.20.
30 Oct: open ₹263.50, high ₹265.65, low ₹257.00
52-week range of traded prices to 30 Oct 2026
₹124.11Low, 24 Mar 2026₹403.35High, 1 Sep 2026
- Next results date: the board meets on 5 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹7,314 Cr806th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −100.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −63.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,27,67850.0% delivered
Suven Life Sciences board meetings
122 filed, newest first. Page 3 of 3.
Oct 2010
19 Oct · Board meeting
To consider, inter alia and to take on record the Un-audited Financial Results for the Second Quarter ended September 30, 2010.
Jul 2010
19 Jul · Board meeting
To consider, inter alia and to take on record the Un-audited Financial Results for the First Quarter ended June 30, 2010.
Apr 2010
22 Apr · Board meeting
To Consider, inter alia, and take on record the followings matters: (1) To consider and approve the Audited Annual Accounts for the year ended March 31, 2010. (2) to consider and recommend dividend if any, for the financial year 2009-2010.
Jan 2010
19 Jan · Board meeting
Meeting on 27 Jan 2010: “Unaudited Financial Results for the qtr ended Dec 31, 2009”
Oct 2009
21 Oct · Board meeting
Meeting on 31 Oct 2009: “Unaudited Financial Results for the Qtr ended Sept 30, 2009”
Sep 2009
14 Sep · Board meeting
To consider inter alia and approve Cost Accounts of the Company for the year 2008-09.
Jul 2009
20 Jul · Board meeting
To consider, inter alia, and take on record the following matters: (1) To consider and approve the Audited Annual Accounts for the year ended March 31, 2009. (2) To recommend dividend for the financial year ended March 31, 2009, if any (3) To announce Book Closure for the purpose of AGM . (4) To consider and take on record the Un-audited Financial Results for the First Quarter ended June 30, 2009.
Apr 2009
21 Apr · Board meeting
To consider, inter alia, and take on record the Un-audited Financial Results for the Fourth Quarter ended March 31, 2009.
Jan 2009
9 Jan · Board meeting
Meeting on 19 Jan 2009: “Unaudited Financial Results for the qtr ended Dec 31, 2008”
Oct 2008
21 Oct · Board meeting
Meeting on 31 Oct 2008: “Unaudited financial results for qtr ended September 30, 2008”
Sep 2008
22 Sep · Board meeting
Board of Directors at their meeting held on September 18, 2008, have approved the Cost Accounts for the year 2007-08.11 Sep · Board meeting
To consider and approve Cost Accounts of the Company for the year 2007-08.
Jul 2008
16 Jul · Board meeting
To consider, inter alia, and take on record the following matters: (1) To consider and approve the Audited Annual Accounts for the year ended March 31, 2008. (2) To recommend dividend for the financial year ended March 31, 2008, subject to approval of Shareholders at the ensuing AGM. (3) To announce Book Closure for the purpose of AGM and distribution of Dividend. (4) To consider and take on record the Un-audited Financial Results for the First Quarter ended June 30, 2008.
Apr 2008
15 Apr · Board meeting
Inter alia, to consider and take on record the Un-audited Financial Results for the Quarter ended March 31, 2008.
Jan 2008
17 Jan · Board meeting
Meeting on 28 Jan 2008: “Unaudited Financial Results for the qtr ended Dec 31, 2007”
Oct 2007
17 Oct · Board meeting
Meeting on 30 Oct 2007: “Unaudited Financial Results for the Qtr ended Sept 30, 2007”
Sep 2007
18 Sep · Board meeting
To consider and approve Cost Accounts of the Company for the year 2006-07.
Jul 2007
23 Jul · Board meeting
To consider, inter alia, and take on record the following matters: (1) To consider and approve the Annual Accounts for the year ended March 31, 2007. (2) To recommend dividend for the financial year ended March 31, 2007 subject to approval of Shareholders at the ensuing AGM. (3) To announce Book Closure for the purpose of AGM and distribution of Dividend. (4) To consider and take on record the Un-audited Financial Results for the First Quarter ended June 30, 2007.
Apr 2007
18 Apr · Board meeting
Meeting on 26 Apr 2007: “Unaudited Financial Results for the Qtr ended March 31, 2007”2 Apr · Board meeting
A meeting of committee of Board of Directors of our company will be held on Friday 6th April ,2007 at 11.30 a.m. to consider and allot bonus shares in the ratio of 1:1 to the members of the Company whose names borne on the Register of Members as on the Record Date
Mar 2007
5 Mar · Board meeting
To consider and announce the Record Date for the purpose of sub-division of shares from Rs 2/- each to Re 1/- each as well as for issue of Bonus shares, subject to approval of the members in the ensuing Extra-Ordinary General Meeting to be held on March 10, 2007.
Jan 2007
22 Jan · Board meeting
Inter alia, to consider the following. (1) Take on record the Un-audited Financial Results for the Quarter ended 31st December 2006. (2) To consider sub-division of equity shares and (3) To consider issue of Bonus shares.